133 related articles for article (PubMed ID: 26960924)
21. What is the phenotype of patients with gastrointestinal intolerance to metformin?
Hermans MP; Ahn SA; Rousseau MF
Diabetes Metab; 2013 Sep; 39(4):322-9. PubMed ID: 23786968
[TBL] [Abstract][Full Text] [Related]
22. Metabolic syndrome in adult patients with Prader-Willi syndrome.
Grugni G; Crinò A; Bedogni G; Cappa M; Sartorio A; Corrias A; Di Candia S; Gargantini L; Iughetti L; Pagano C; Ragusa L; Salvatoni A; Spera S; Vettor R; Chiumello G; Brambilla P
Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1134-40. PubMed ID: 23220075
[TBL] [Abstract][Full Text] [Related]
23. Association of metabolic syndrome components with insulin resistance in normal weight population: the Qazvin Metabolic Diseases study.
Hashemipour S; Esmailzadehha N; Hamid H; Oveisi S; Yakhchaliha P; Ziaee A
J Endocrinol Invest; 2015 Oct; 38(10):1111-5. PubMed ID: 25952300
[TBL] [Abstract][Full Text] [Related]
24. Association of serum chemerin and inflammatory factors with type 2 diabetes macroangiopathy and waist-to-stature ratio.
Yang M; Zhou X; Xu J; Yang B; Yu J; Gong Q; Zhang X; Sun X; Zhang Q; Xia J; Li J
Bosn J Basic Med Sci; 2019 Nov; 19(4):328-335. PubMed ID: 31078135
[TBL] [Abstract][Full Text] [Related]
25. Serum Levels of Soluble CD26/Dipeptidyl Peptidase-IV in Type 2 Diabetes Mellitus and Its Association with Metabolic Syndrome and Therapy with Antidiabetic Agents in Malaysian Subjects.
Ahmed RH; Huri HZ; Al-Hamodi Z; Salem SD; Muniandy S
PLoS One; 2015; 10(10):e0140618. PubMed ID: 26474470
[TBL] [Abstract][Full Text] [Related]
26. Serum magnesium in the metabolically-obese normal-weight and healthy-obese subjects.
Guerrero-Romero F; Rodriguez-Moran M
Eur J Intern Med; 2013 Oct; 24(7):639-43. PubMed ID: 23523313
[TBL] [Abstract][Full Text] [Related]
27. The magnitude of obesity and metabolic syndrome among diabetic chronic kidney disease population: A nationwide study.
Kittiskulnam P; Thokanit NS; Katavetin P; Susanthitaphong P; Srisawat N; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
PLoS One; 2018; 13(5):e0196332. PubMed ID: 29742114
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the prevalence of metabolic obesity and normal weight among the Polish population.
Bednarek-Tupikowska G; Stachowska B; Miazgowski T; Krzyżanowska-Świniarska B; Katra B; Jaworski M; Kuliczkowska-Płaksej J; Jokiel- Rokita A; Tupikowska M; Bolanowski M; Jędrzejuk D; Milewicz A
Endokrynol Pol; 2012; 63(6):447-55. PubMed ID: 23339002
[TBL] [Abstract][Full Text] [Related]
29. Oxidized HDL and LDL in adolescents with type 2 diabetes compared to normal weight and obese peers.
Marin MT; Dasari PS; Tryggestad JB; Aston CE; Teague AM; Short KR
J Diabetes Complications; 2015 Jul; 29(5):679-85. PubMed ID: 25881918
[TBL] [Abstract][Full Text] [Related]
30. Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals.
Voulgari C; Tentolouris N; Dilaveris P; Tousoulis D; Katsilambros N; Stefanadis C
J Am Coll Cardiol; 2011 Sep; 58(13):1343-50. PubMed ID: 21920263
[TBL] [Abstract][Full Text] [Related]
31. Plasma SFRP5 levels are decreased in Chinese subjects with obesity and type 2 diabetes and negatively correlated with parameters of insulin resistance.
Hu Z; Deng H; Qu H
Diabetes Res Clin Pract; 2013 Mar; 99(3):391-5. PubMed ID: 23290274
[TBL] [Abstract][Full Text] [Related]
32. Age-dependent systemic DNA damage in early Type 2 Diabetes mellitus.
Rogulj D; El Aklouk I; Konjevoda P; Ljubić S; Pibernik Okanović M; Barbir A; Luburić M; Radman M; Budinski N; Vučić Lovrenčić M
Acta Biochim Pol; 2017; 64(2):233-238. PubMed ID: 28350403
[TBL] [Abstract][Full Text] [Related]
33. Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals.
Succurro E; Marini MA; Frontoni S; Hribal ML; Andreozzi F; Lauro R; Perticone F; Sesti G
Obesity (Silver Spring); 2008 Aug; 16(8):1881-6. PubMed ID: 18551117
[TBL] [Abstract][Full Text] [Related]
34. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes.
Bello-Chavolla OY; Almeda-Valdes P; Gomez-Velasco D; Viveros-Ruiz T; Cruz-Bautista I; Romo-Romo A; Sánchez-Lázaro D; Meza-Oviedo D; Vargas-Vázquez A; Campos OA; Sevilla-González MDR; Martagón AJ; Hernández LM; Mehta R; Caballeros-Barragán CR; Aguilar-Salinas CA
Eur J Endocrinol; 2018 May; 178(5):533-544. PubMed ID: 29535168
[TBL] [Abstract][Full Text] [Related]
35. Do high ferritin levels confer lower cardiovascular risk in men with Type 2 diabetes?
Hermans MP; Ahn SA; Amoussou-Guenou KD; Balde NM; Rousseau MF
Diabet Med; 2010 Apr; 27(4):417-22. PubMed ID: 20536513
[TBL] [Abstract][Full Text] [Related]
36. Lean, but not healthy: the 'metabolically obese, normal-weight' phenotype.
Ding C; Chan Z; Magkos F
Curr Opin Clin Nutr Metab Care; 2016 Nov; 19(6):408-417. PubMed ID: 27552473
[TBL] [Abstract][Full Text] [Related]
37. Circulating Unsaturated Fatty Acids Delineate the Metabolic Status of Obese Individuals.
Ni Y; Zhao L; Yu H; Ma X; Bao Y; Rajani C; Loo LW; Shvetsov YB; Yu H; Chen T; Zhang Y; Wang C; Hu C; Su M; Xie G; Zhao A; Jia W; Jia W
EBioMedicine; 2015 Oct; 2(10):1513-22. PubMed ID: 26629547
[TBL] [Abstract][Full Text] [Related]
38. Atherogenecity of LDL and unfavorable adipokine profile in metabolically obese, normal-weight woman.
Hyun YJ; Koh SJ; Chae JS; Kim JY; Kim OY; Lim HH; Jang Y; Park S; Ordovas JM; Lee JH
Obesity (Silver Spring); 2008 Apr; 16(4):784-9. PubMed ID: 18239579
[TBL] [Abstract][Full Text] [Related]
39. Clinical and Body Compositional Factors Associated with Metabolic Syndrome in Obese Koreans: A Cross-Sectional Study.
Kim YM; Kim S; Kim SH; Won YJ
Metab Syndr Relat Disord; 2018 Aug; 16(6):290-298. PubMed ID: 29717940
[TBL] [Abstract][Full Text] [Related]
40. Clinical correlations and genetic associations of metabolic syndrome in the United Arab Emirates.
Osman WM; Khan SM; Jelinek HF; Almahmeed W; Tay GK; Alsafar HS
Gene; 2020 May; 738():144476. PubMed ID: 32061761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
